Ocean Biodiversity Information System

The Metals Company Provides Second Quarter 2023 Corporate Update and Commentary on ~$27 Million Capital Raise at $2.00 Per Share with Potential Upsizing to $38 Million

Retrieved on: 
Monday, August 14, 2023
Exercise, OBIS, International Seabed Authority, Ocean Biodiversity Information System, Project Zero, National security, United States House Armed Services Subcommittee on Strategic Forces, NDAA, Record, Environmental policy of the Joe Biden administration, Mining Code, Assistant, The Metals Company, TMC, United States House Committee on Armed Services, Allseas, U.S. Department of Defense Strategy for Operating in Cyberspace, Mining, Engineering, Motivation, Corporation, ISA, Part Two, Carl Levin and Howard P. "Buck" McKeon National Defense Authorization Act for Fiscal Year 2015, Policy, Letter, The Hidden Gem, House, PMTS, Presidency of Joe Biden, Cryptocurrency, Management, Security (finance), Defense

Chairman and CEO Gerard Barron and CFO Craig Shesky along with several TMC board members also participated in the transaction.

Key Points: 
  • Chairman and CEO Gerard Barron and CFO Craig Shesky along with several TMC board members also participated in the transaction.
  • Exploration evaluation expenses during the quarter ended June 30, 2023 were $8.1 million compared to $10.2 million for the quarter ended June 30, 2022.
  • General and administrative expenses were $5.1 million for the quarter ended June 30, 2023 compared to $8.1 million for the quarter ended June 30, 2022.
  • ET to provide an update on recent corporate developments, first quarter financial results and upcoming milestones.

OBiS Incorporated, A Healthcare and Biotechnology Consulting Company, Opens Subsidiary Office in Oloron-Sainte-Marie, France

Retrieved on: 
Tuesday, March 9, 2021
Biotechnology, Pharmaceutical, General Health, Health, Consulting, Data management, Professional services, Technology, Ecology, Branches of biology, Biology, OLORON-SAINTE-MARIE, Ocean Biodiversity Information System

OBiS Incorporated, a New York City based healthcare and biotechnology consulting company, has announced the opening of a subsidiary office in Oloron-Sainte-Marie, France.

Key Points: 
  • OBiS Incorporated, a New York City based healthcare and biotechnology consulting company, has announced the opening of a subsidiary office in Oloron-Sainte-Marie, France.
  • The purpose of the new French subsidiary will be to expand its healthcare related clinical medicine, marketing and finance analytics capabilities to better serve the European market.
  • Company founder, Rick Beasley , foresees tremendous opportunity being located in France, given its pivotal role in the development of medicine throughout history.
  • OBiS plans to promote both the scientific as well as the financial aspects of biotechnology which it considers important to advance a global leadership position.